PADDI wins top clinical trials award

23 May 2022

The ANZCA CTN endorsed PADDI trial has been recognised on International Clinical Trials Day.

The Perioperative Administration of Dexamethasone and Infection (PADDI) trial is the recipient of the 2022 Australian Clinical Trials Alliance (ACTA) Excellence in Trial Statistics Award.

The award was presented on International Clinical Trials Day which is held on 20 May each year to recognise the outstanding contribution of the sector in developing and leading investigator-led clinical trials.

The Excellence in Trial Statistics Award is assessed by a panel of senior statisticians who said the PADDI trial demonstrates exemplary statistical aspects from trial design and planning through to analysis reporting and interpretation. Professor Andrew Forbes, the lead trial statistician based at Monash University’s School of Public Health and Preventive Medicine, accepted the award on behalf of the PADDI investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network (ANZCA CTN).

The PADDI trial led by Chief Investigator Professor Tomas Corcoran, Director of Research in the Department of Anaesthesia and Pain Medicine, Royal Perth Hospital and Deputy Chair of the ANZCA CTN Executive, was funded by the National Health and Medical Research Council and co-ordinated at the ANZCA CTN office based at Monash University.

Read the media release.
 


Last updated 10:27 23.05.2022